why choose us

First received: December 04, 2023

Clinical Trial: Telmisartan in Prostate Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: Phase I Non-Randomized, Unblinded, Single-Center Trial of Oral Telmisartan Alone or Combined With Selected Standard of Care Therapies for Prostate Cancer

Brief Summary: The goal of this clinical trial is to learn about the tolerability of telmisartan in patients with prostate cancer.

Read more